Clinical observation study of the safety, effectiveness and tolerability of exenatide in a real-world setting

被引：0
|
作者：
Briceno, Rosanna M.
Lagari-Libhaber, Violet S.
Meneghini, Luigi F.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A544 / A544
页数：1
相关论文
共 50 条
  • [21] Real-World Efficacy, Tolerability and Safety of Ubrogepant
    Chiang, C. C.
    Arca, K.
    Dunn, R.
    Girardo, M.
    Quillen, J.
    Dodick, D. W.
    Starling, A.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 142 - 143
  • [22] Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study
    Nozawa, Yumiko
    Kato, Daisuke
    Tabuchi, Hiromi
    Kuroishi, Kentarou
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2018, 10 (02) : 122 - 130
  • [23] Comparative Glycemic Effectiveness of Dulaglutide vs. Liraglutide and Exenatide QW in a US Real-World Setting
    Mody, Reema
    Huang, Qing
    Yu, Maria
    Patel, Hiren
    Zhao, Ruizhi
    Grabner, Michael
    Lando, Laura Fernandez
    DIABETES, 2018, 67
  • [24] Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting
    Bergenstal, Richard M.
    Garrison, Louis P., Jr.
    Wintle, Matthew
    Blickensderfer, Amy
    Wade, Rolin
    Hou, Likun
    Miller, Lesley-Ann
    Scism-Bacon, Jamie
    Zagar, Anthony
    Misurski, Derek
    Herman, William H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (03) : 531 - 540
  • [25] Comparative glycaemic effectiveness of dulaglutide vs liraglutide and exenatide once weekly in a US real-world setting
    Mody, R.
    Huang, Q.
    Yu, M.
    Patel, H.
    Zhao, R.
    Grabner, M.
    Lando, L. Fernandez
    DIABETOLOGIA, 2018, 61 : S363 - S363
  • [26] Effectiveness in a Real-World Observation Confirms Efficacy of Controlled Clinical Trials
    Kappetein, Arie Pieter
    Vahanian, Alec
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (04) : 451 - 452
  • [27] Real-world effectiveness and safety of alirocumab
    Mondelo Garcia, C.
    Garcia Queiruga, M.
    Balea Filgueiras, J.
    Fernandez Bargiela, N.
    Gimenez Arufe, V.
    Fernandez Oliveira, C.
    Martin Herranz, M. I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 377 - 378
  • [28] Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia
    Colbert, Gates
    Sannapaneni, Shilpa
    Lerma, Edgar, V
    DRUG HEALTHCARE AND PATIENT SAFETY, 2022, 14 : 87 - 96
  • [29] Effectiveness and safety of belimumab in patients with systemic lupus erythematosus in a real-world setting
    Anjo, C.
    Mascaro, J-M, Jr.
    Espinosa, G.
    Cervera, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2019, 48 (06) : 469 - 473
  • [30] Effectiveness and Safety of Aliskiren and Aliskiren Hydrochlorothiazide (HCT) in a Multiethnic, Real-World Setting
    Srinivasa Rao Maddury
    Abhay Pande
    K. M. H. S. Sirajul Haque
    Akram Echtay
    Loewe Go
    Tashbeeb Gulzar
    Mahomed Kadwa
    Sashka Hristoskova
    Advances in Therapy, 2013, 30 : 176 - 189
12345